Numerous studies have found that SIRT7 is typically highly expressed in various human malignancies, including breast cancer, clear cell renal cell carcinoma, lung adenocarcinoma, prostate adenocarcinoma, hepatocellular carcinoma, and gastric cancer [93, 94, 95, 96]. This evidence concerns the gene SIRT7 and hepatocellular carcinoma.